心血管磁共振成像机遇与挑战——中国十年来发展成果及展望  

Opportunities and challenges of cardiovascular magnetic resonance imaging:Achievements and prospects over the past decade in China

作　　者：冯长静 杨旗 FENG Changjing;YANG Qi(Department of Interventional Radiology Imaging Center,Chaoyang Hospital,Capital Medical University,Beijing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院放射介入影像中心,北京100020

出　　处：《磁共振成像》2022年第10期66-70,78,共6页Chinese Journal of Magnetic Resonance Imaging

基　　金：国家杰出青年科学基金(编号:82025018)。

摘　　要：近十年来,心血管磁共振(cardiovascular magnetic resonance,CMR)成像技术作为一种无创性评估心脏结构与功能的“金标准”,已在国内心血管疾病临床诊疗领域发挥了重要作用。伴随着组织学特征成像、特征追踪技术、扩散加权成像、影像组学和人工智能等新技术的出现,CMR为心血管系统疾病精准诊疗提供了新的机遇。国内许多医院已经采用CMR对缺血性心脏病、非缺血性心脏病、大血管疾病等进行精准评估,取得了系列研究成果。相信未来CMR将在组织学特征成像、影像组学和人工智能、分子成像以及疾病的早期诊断、危险分层、预后评估等方面取得更大的研究成果。本文对十年来国内CMR领域临床和科研进展进行总结,并展望未来发展方向,以期为CMR技术研究与临床研究提供相关参考。In the past decade,cardiovascular magnetic resonance(CMR)imaging,as a gold standard for noninvasive assessment of cardiac structure and function,has played an important role in the clinical diagnosis and treatment of cardiovascular diseases in China.With the advent of new techniques such astissue characterization imaging,feature tracking technology,diffusion-weighted imaging,radiomics and artificial intelligence,CMR provides new opportunities for precise diagnosis and treatment of cardiovascular system diseases.Several domestic hospitals have used CMR to accurately evaluate ischemic heart disease,non-ischemic heart disease,macrovascular disease,etc.,and have obtained a series of research results.We believe that CMR will achieve greater research results in tissue characterization imaging,radiomics and artificial intelligence,molecular imagingas well as early diagnosis,risk stratification,and prognostic evaluation of the disease in the future.We summarized the clinical and scientific research progress in the field of CMR in China in the past ten years,and looks forward to the future development direction in this paper,in order to provide relevant reference for the research of CMR technology and clinical research.

关 键 词：缺血性心脏病 非缺血性心脏病 心肌病 冠状动脉粥样硬化 大血管疾病 心血管磁共振成像 磁共振血管造影 钆对比剂延迟强化 心脏磁共振特征追踪 扩散加权成像 影像组学 人工智能 预后 疗效评价 

分 类 号：R445.2[医药卫生—影像医学与核医学]